Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.16.6881

Roles of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios in the Early Diagnosis of Malignant Ovarian Masses  

Yildirim, Mem Arjen (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Seckin, Kerem Doga (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Togrul, Cihan (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Baser, Eralp (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Karsli, Mehmet Fatih (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Gungor, Tayfun (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Gulerman, Hacer Cavidan (Obstetrics and Gynecology Department of Zekai Tahir Burak Women's Health and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.16, 2014 , pp. 6881-6885 More about this Journal
Abstract
Background: The present study aimed to investigate the utility and importance of the various parameters of complete blood count panel for benign-malignant differentiation of adnexal masses. Materials and Methods: This retrospective study involved 316 patients with documented benign and 253 patients with malignant adnexal masses who underwent primary surgical treatment at a tertiary referral center. Prior to the study, all benign and malignant cases were compared within their own groups and then the benign and malignant cases were compared to each other. For all cases, cut-off, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for the neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), neutrophil, lymphocyte, platelet and CA-125 parameters, and the results were compared in regards to the groups. Results: NLR, PLR, neutrophil, CA-125, and platelet values were higher in the malignant compared to the benign cases (p<0.01). The lymphocyte value was lower in the malignant cases (p<0.01). No significant differences were found for basophils and eosinophils (p > 0.05). For CA-125, the sensitivity, specificity, PPV and NPV for all cases were 78%, 62%, 62% and 78%, respectively. For NLR, they were 65.6%, 72.1%, 65.3%, and 72.3%, and for PLR, 48%, 81%, 67%, and 66%. Additionally, the sensitivity and specificity were 55% and 77% for CA-125, 66% and 58% for NLR, and 61% and 58% for PLR in early malignant cases. Conclusions: NLR and PLR appear to be useful methods that can be applied together with CA-125 due to the relatively high sensitivity values for the malign-benign differentiation of ovarian masses. Although the specificity of these parameters is lower than CA-125, especially in cases with early malignant ovarian pathology, their sensitivity being higher is promising for the early diagnosis of ovarian cancer. It can be used to detect ovarian malignancies in the early stages, and it will increase the treatment options and improve survival rates.
Keywords
Neutrophil lymphocyte ratio; platelet lymphocyte ratio; ovarian mass; CA-125;
Citations & Related Records
Times Cited By KSCI : 8  (Citation Analysis)
연도 인용수 순위
1 Pauler DK, Menon U, Mcintosh M, et al (2001). Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev, 10, 489-93.
2 Suh DH, Kim HS, Chung HH, et al (2012). Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol, 162, 206-10.   DOI
3 Thavaramara T, Phaloprakarn C, Tangjitgamol S, Manusirivithaya S (2011). Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 94, 871-7.
4 Ueno H, Hawrylowicz CM, Banchereau J (2007). Immunological intervention in human diseases. J Transl Med, 5, 59.   DOI
5 Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.   과학기술학회마을   DOI   ScienceOn
6 Van Der Auwera I, Van Laere SJ, Van Den Eynden GG, et al (2004). Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res, 10, 7965-71.   DOI
7 Wang W, Bergh A, Damber JE (2004). Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate, 61, 60-72.   DOI   ScienceOn
8 Winarto H, Laihad BJ, Nuranna L (2014). Modification of cutoff values for HE4, CA125, the risk of malignancy index and the risk of malignancy algorithm for ovarian cancer detection in Jakarta, Indonesia. Asian Pac J Cancer Prev, 15, 1949-53.   과학기술학회마을   DOI   ScienceOn
9 Ardies CM (2003). Inflammation as cause for scar cancers of the lung. Integr Cancer Ther, 2, 238-46.   DOI   ScienceOn
10 Altinoz MA, Korkmaz R (2004). NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma, 51, 239-47.
11 Arun-Muthuvel V, Jaya V (2014). Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound. Asian Pac J Cancer Prev, 15, 2929-32.   과학기술학회마을   DOI   ScienceOn
12 Bast RC, Jr. Badgwell D, Lu Z, et al (2005). New tumor markers: CA125 and beyond. Int J Gynecol Cancer, 15, 274-81.   DOI   ScienceOn
13 Asher V, Lee J, Innamaa A, Bali A (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503.   DOI   ScienceOn
14 Ashrafgangooei T, Rezaeezadeh M (2011). Risk of malignancy index in preoperative evaluation of pelvic masses. Asian Pac J Cancer Prev, 12, 1727-30.
15 Bartsch H, Nair J (2004). Oxidative stress and lipid peroxidationderived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect Prev, 28, 385-91.   DOI
16 Bast RC, Jr Xu FJ, Yu YH, et al (1998). CA 125: the past and the future. Int J Biol Markers, 13, 179-87.
17 Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet, 70, 209-62.   DOI   ScienceOn
18 Bian J, Li B, Kou XJ, Liu TZ, Ming L (2013). Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer. Asian Pac J Cancer Prev, 14, 6241-3.   과학기술학회마을   DOI   ScienceOn
19 Brower V (2005). Feeding the flame: new research adds to role of inflammation in cancer development. J Natl Cancer Inst, 97, 251-3.   DOI
20 Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23.   DOI   ScienceOn
21 Gadducci A, Cosio S, Tana R, Genazzani AR (2009). Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol, 69, 12-27.   DOI
22 Cho S, Cho H, Nam A, et al (2008). Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril, 90, 2073-9.   DOI   ScienceOn
23 Crasta JA, Premlatha TS, Krishnan SM, Vallikad E, Rameshkumar K (2010). Significance of preoperative thrombocytosis in epithelial ovarian cancer. Indian J Pathol Microbiol, 53, 54-6.   DOI
24 Dirican A, Kucukzeybek Y, Erten C, et al (2013). Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha. Asian Pac J Cancer Prev, 14, 2101-5.   과학기술학회마을   DOI   ScienceOn
25 Guzel AI, Kokanali MK, Erkilinc S, et al (2014). Predictive role of the neutrophil lymphocyte ratio for invasion with gestational trophoblastic disease. Asian Pac J Cancer Prev, 15, 4203-06.   과학기술학회마을   DOI
26 Hussein MR, Ahmed RA (2005). Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pretumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther, 4, 819-21.   DOI
27 Jaiswal M, Larusso NF, Gores GJ (2001). Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol, 281, 626-34.
28 Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.   DOI   ScienceOn
29 Karaman H, Karaman A, Erden A, et al (2013) Relationship between colonic polyp type and the neutrophil/ lymphocyte ratio as a biomarker. Asian Pac J Cancer Prev, 14, 3159-61.   과학기술학회마을   DOI   ScienceOn
30 Jilma B, Blann A, Pernerstorfer T, et al (1999). Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med, 159, 857-63.   DOI
31 Kim HS, Han KH, Chung HH, et al (2010). Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol, 36, 691-8.   DOI   ScienceOn
32 Kuyumcuoglu U, Guzel AI, Celik Y, Erdemoglu M (2010). The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynaecol Oncol, 31, 514-6.
33 Landis SH, Murray T, Bolden S, Wingo PA (1998). Cancer statistics, 1998. CA Cancer J Clin, 48, 6-29.   DOI   ScienceOn
34 Lee M, Kim SW, Nam EJ, et al (2011). The impact of pretreatment thrombocytosis, persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol, 122, 238-41.   DOI   ScienceOn
35 Lee YY, Choi CH, Kim HJ, et al (2012). Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res, 32, 1555-61.
36 Li AJ, Madden AC, Cass I, et al (2004). The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol, 92, 211-4.   DOI   ScienceOn
37 Li L, Xu Y, Yu CX (2012). Proteomic analysis of serum of women with elevated Ca-125 to differentiate malignant from benign ovarian tumors. Asian Pac J Cancer Prev, 13, 3265-70.   과학기술학회마을   DOI   ScienceOn